Medicaid MCOs Try Outreach, Cash to Move Needle on Vaccines

As the COVID-19 pandemic has entered a grim new phase thanks to the virulent Delta variant, the need to vaccinate everyone eligible has become even more urgent. State public health data and polls indicate that Medicaid beneficiaries are disproportionately likely to be unvaccinated — something that safety net health plans are working hard to change.

Medicaid MCOs across the country are using all the tools at their disposal to encourage their members to get vaccinated — some Medicaid health plans are even offering members cash incentives. Plans are also helping members schedule vaccination appointments and arranging transportation to them. And MCOs are working to persuade members that vaccines are safe and effective, even as the rollout of vaccine booster shots is being discussed by the Biden administration.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has worked as a journalist since 2011 and has covered health care since 2020. At AIS Health, Peter covers trends in finance, business and policy that affect the health insurance and pharma sectors. For Health Plan Weekly, he covers all aspects of the U.S. health insurance sector, including employer-sponsored insurance, Medicaid managed care, Medicare Advantage and the Affordable Care Act individual marketplaces. In Radar on Drug Benefits, Peter covers the operations of (and conflicts between) pharmacy benefit managers and pharmaceutical manufacturers, with a particular focus on pricing dynamics and market access. Before joining AIS Health, Peter covered transportation, public safety and local government for various outlets in Seattle, his hometown and current place of residence. He graduated with a B.A. from Colby College.

Related Posts

needle-and-bills
September 6

Health Care Utilization Outpaces Pre-Pandemic Levels in Early 2024

READ MORE
happy-guys-on-computer
September 6

CareFirst’s Involvement in Startup Accelerator Shows its Intrigue With AI

READ MORE
cigna-on-laptop
September 6

Cigna CEO Offers Medical Cost Update, Touts Stelara Biosimilar

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today